144 related articles for article (PubMed ID: 18822682)
1. Correlation between magnetic resonance imaging and histopathological tumor response after neoadjuvant chemotherapy in breast cancer.
Nicoletto MO; Nitti D; Pescarini L; Corbetti F; Mencarelli R; Cappetta A; Galligioni A; Pogliani C; Marchet A; Bozza F; Ghiotto C; Griggio L; Zavagno G; Donach ME; Di Maggio C
Tumori; 2008; 94(4):481-8. PubMed ID: 18822682
[TBL] [Abstract][Full Text] [Related]
2. Docetaxel followed by fluorouracil/epirubicin/cyclophosphamide as neoadjuvant chemotherapy for patients with primary breast cancer.
Iwata H; Sato N; Masuda N; Nakamura S; Yamamoto N; Kuroi K; Kurosumi M; Tsuda H; Akiyama F; Ohashi Y; Toi M
Jpn J Clin Oncol; 2011 Jul; 41(7):867-75. PubMed ID: 21719750
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breast cancer: phase III randomized GeparTrio trial.
von Minckwitz G; Kümmel S; Vogel P; Hanusch C; Eidtmann H; Hilfrich J; Gerber B; Huober J; Costa SD; Jackisch C; Loibl S; Mehta K; Kaufmann M;
J Natl Cancer Inst; 2008 Apr; 100(8):542-51. PubMed ID: 18398097
[TBL] [Abstract][Full Text] [Related]
4. High pathologic complete response in HER 2-positive locally advanced breast cancer after primary systemic chemotherapy with weekly docetaxel and epirubicin.
Chen SC; Chang HK; Lin YC; Hsueh S; Cheung YC; Leung WM; Tsai CS; Lo YF; Tsai HP; Shen SC; Chen MF
Jpn J Clin Oncol; 2008 Feb; 38(2):99-105. PubMed ID: 18270380
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant sequential epirubicin and docetaxel followed by surgery-radiotherapy and post-operative docetaxel or gemcitabine/vinorelbine combination based on primary response: a multimodality approach for locally advanced breast cancer.
Kountourakis P; Missitzis I; Doufexis D; Zobolas V; Pissakas G; Arnogiannaki N; Maliou S; Sotiropoulou A; Ardavanis A
J Cancer Res Clin Oncol; 2011 Feb; 137(2):221-8. PubMed ID: 20387073
[TBL] [Abstract][Full Text] [Related]
6. Assessment of response by breast helical computed tomography to neoadjuvant chemotherapy in large inflammatory breast cancer.
Moyses B; Haegele P; Rodier JF; Lehmann S; Petit T; Velten M; Schraub S
Clin Breast Cancer; 2002 Jan; 2(4):304-10. PubMed ID: 11899363
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of neoadjuvant docetaxel/ vinorelbine followed by surgery and adjuvant doxorubicin/cyclophosphamide in women with stage II/III breast cancer.
Limentani SA; Brufsky AM; Erban JK; Jahanzeb M; Lewis D
Clin Breast Cancer; 2006 Feb; 6(6):511-7. PubMed ID: 16595034
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant 5-fluorouracil, epirubicin and cyclophosphamide chemotherapy followed by docetaxel in refractory patients with locally advanced breast cancer.
Heller W; Mazhar D; Ward R; Sinnett HD; Lowdell C; Phillips R; Shousha S; Fayaz A; Palmieri C; Coombes RC
Oncol Rep; 2007 Jan; 17(1):253-9. PubMed ID: 17143506
[TBL] [Abstract][Full Text] [Related]
9. Combination of vinorelbine, epirubicin, and cyclophosphamide as neoadjuvant chemotherapy for locally advanced breast cancer: phase II study.
Braud AC; Levy E; Feuilhade F; Otmezguine Y; Calitchi E; Kirova Y; Le Bourgeois JP
Am J Clin Oncol; 2002 Jun; 25(3):303-7. PubMed ID: 12040294
[TBL] [Abstract][Full Text] [Related]
10. Contrast enhanced magnetic resonance imaging underestimates residual disease following neoadjuvant docetaxel based chemotherapy for breast cancer.
Denis F; Desbiez-Bourcier AV; Chapiron C; Arbion F; Body G; Brunereau L
Eur J Surg Oncol; 2004 Dec; 30(10):1069-76. PubMed ID: 15522553
[TBL] [Abstract][Full Text] [Related]
11. Can early response assessment guide neoadjuvant chemotherapy in early-stage breast cancer?
Esteva FJ; Hortobagyi GN
J Natl Cancer Inst; 2008 Apr; 100(8):521-3. PubMed ID: 18398093
[No Abstract] [Full Text] [Related]
12. Preoperative second-line chemotherapy induces objective responses in primary breast cancer.
Wenzel C; Locker GJ; Bartsch R; Pluschnig U; Hussian D; Zielinski CC; Rudas M; Gnant MF; Jakesz R; Steger GG
Wien Klin Wochenschr; 2005 Jan; 117(1-2):48-52. PubMed ID: 15986591
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant triweekly nanoparticle albumin-bound paclitaxel followed by epirubicin and cyclophosphamide for Stage II/III HER2-negative breast cancer: evaluation of efficacy and safety.
Shimada H; Ueda S; Saeki T; Shigekawa T; Takeuchi H; Hirokawa E; Sugitani I; Sugiyama M; Takahashi T; Matsuura K; Yamane T; Kuji I; Hasebe T; Osaki A
Jpn J Clin Oncol; 2015 Jul; 45(7):642-9. PubMed ID: 25989989
[TBL] [Abstract][Full Text] [Related]
14. [Assessment of neoadjuvant chemotherapy in breast cancer patients].
Zhang B; Zhang Q; Zhao L; Long F; Li S; Jiang DQ; Xu H
Zhonghua Zhong Liu Za Zhi; 2006 Nov; 28(11):867-70. PubMed ID: 17416014
[TBL] [Abstract][Full Text] [Related]
15. The actual scenario of neoadjuvant chemotherapy of breast cancer in developing country: a report of 80 cases of breast cancer from a tertiary cancer center in India.
Das U; Lakshmaiah KC; Govind Babu K; Suresh TM; Lokanatha D; Jacob L; Babu S
J Cancer Res Clin Oncol; 2014 Oct; 140(10):1777-82. PubMed ID: 24894013
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of neoadjuvant docetaxel, vinorelbine, and trastuzumab followed by surgery and adjuvant doxorubicin plus cyclophosphamide in women with human epidermal growth factor receptor 2-overexpressing locally advanced breast cancer.
Limentani SA; Brufsky AM; Erban JK; Jahanzeb M; Lewis D
J Clin Oncol; 2007 Apr; 25(10):1232-8. PubMed ID: 17296975
[TBL] [Abstract][Full Text] [Related]
17. [Neoadjuvant treatment for locally advanced breast cancer. Comparison of two schemes based on docetaxel-epirubicin vs. 5-fluorouracil-epirubicin-cyclophosphamide].
Cortés-Flores AO; Morgan-Villela G; Castro-Cervantes JM; Vázquez-Camacho G; Fuentes-Orozco C; González-Ojeda A
Cir Cir; 2008; 76(1):23-8. PubMed ID: 18492416
[TBL] [Abstract][Full Text] [Related]
18. Dynamic contrast-enhanced MR imaging in a phase Ⅱ study on neoadjuvant chemotherapy combining Rh-endostatin with docetaxel and epirubicin for locally advanced breast cancer.
Jia Q; Xu J; Jiang W; Zheng M; Wei M; Chen J; Wang L; Huan Y
Int J Med Sci; 2013; 10(2):110-8. PubMed ID: 23329881
[TBL] [Abstract][Full Text] [Related]
19. Postchemotherapy MRI overestimates residual disease compared with histopathology in responders to neoadjuvant therapy for locally advanced breast cancer.
Kwong MS; Chung GG; Horvath LJ; Ward BA; Hsu AD; Carter D; Tavassoli F; Haffty B; Burtness BA
Cancer J; 2006; 12(3):212-21. PubMed ID: 16803680
[TBL] [Abstract][Full Text] [Related]
20. MRI and conservative treatment of locally advanced breast cancer.
Julius T; Kemp SE; Kneeshaw PJ; Chaturvedi A; Drew PJ; Turnbull LW
Eur J Surg Oncol; 2005 Dec; 31(10):1129-34. PubMed ID: 15905068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
